Beneficial Effects of Chymase Inhibition on Cardiac Diastolic Function and Remodeling Induced by Chronic Angiotensin II Stimulation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178236 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shiguma Taniguchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Osaka Medical and Pharmaceutical University, Takatsuki-City 569-8686, Osaka, Japan. Hauptthemen laut MEDLINE: Chymases, Angiotensin II, Ventricular Remodeling, Diastole. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science, Sports, and Culture in Japan.
Abstract (Originalsprache)
In addition to its role in angiotensin II (Ang II) production, chymase exhibits various functions, including activation of latent transforming growth factor beta 1 (TGF-β1) and pro-matrix metalloproteinases (MMPs). However, the extent to which these Ang II-independent functions contribute to pathological conditions remains unclear. In this study, we investigated the Ang II-independent roles of chymase in cardiac remodeling and dysfunction. Eighteen male Syrian hamsters, aged 6 weeks and weighing 90–110 g, were used. Exogenous Ang II was administered to a hamster model that mirrors the human chymase-dependent Ang II production pathway, via subcutaneous osmotic mini pumps (2 mg/kg/day) for 4 weeks. A chymase-specific inhibitor, TY-51469 (10 mg/kg/day), was given daily starting 1 day after commencement of Ang II infusion. Evaluation showed that while systolic blood pressure increased significantly, only diastolic dysfunction developed over time. Ang II treatment led to elevated cardiac expression of chymase, TGF-β1, and MMP-2, and increased the number of chymase-positive mast cells, resulting in notable cardiac hypertrophy and fibrosis. TY-51469 effectively suppressed these molecular changes and improved both cardiac structure and diastolic dysfunction, despite continued Ang II exposure. These results suggest that chymase promotes cardiac remodeling and dysfunction not only through Ang II generation but also by activating profibrotic and matrix-degrading factors, such as TGF-β1 and MMP-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Osaka Medical and Pharmaceutical University, Takatsuki-City 569-8686, Osaka, Japan.
- Department of Innovative Medicine, Graduate School of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki-City 569-8686, Osaka, Japan.
ORCID-Profile: Denan Jin, Hirofumi Morihara, Shunichi Yokoe, Kazumasa Moriwaki, Shinji Takai
Förderung
- Ministry of Education, Science, Sports, and Culture in Japan
Zitieren
APA
Taniguchi, S., Jin, D., Morihara, H., Yokoe, S., Moriwaki, K., & Takai, S. (2025). Beneficial Effects of Chymase Inhibition on Cardiac Diastolic Function and Remodeling Induced by Chronic Angiotensin II Stimulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178236
Vancouver
Taniguchi S, Jin D, Morihara H, Yokoe S, Moriwaki K, Takai S. Beneficial Effects of Chymase Inhibition on Cardiac Diastolic Function and Remodeling Induced by Chronic Angiotensin II Stimulation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178236
BibTeX
@article{Taniguchi2025,
author = {Taniguchi, Shiguma and Jin, Denan and Morihara, Hirofumi and Yokoe, Shunichi and Moriwaki, Kazumasa and Takai, Shinji},
title = {Beneficial Effects of Chymase Inhibition on Cardiac Diastolic Function and Remodeling Induced by Chronic Angiotensin II Stimulation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178236}
}
EUVIMED